Further trials required but ‘delight’ after early data reveals strong immune response in over-70s
- Coronavirus – latest updates
- See all our coronavirus coverage
Oxford University’s scientists have said there is no rush to publish efficacy results from their Covid vaccine trial, playing down expectations that some of the 100m doses the UK has ordered may be available by Christmas.
Prof Andrew Pollard, chair of the Oxford vaccine group, said they were not in competition with Pfizer/BioNTech and Moderna, which have both published results showing their innovative vaccines successfully protected more than 90% of people from falling ill with Covid-19.
